Andere Sprachen Indivior PLC

Aktien

A3DWFC

GB00BN4HT335

INDV

Pharmazeutika

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:11 29.11.2024			% 5 Tage	% 1. Jan.
885.00 ^GBX	+1.43%		+3.81%	-25.32%

19.11.	Indivior PLC veröffentlicht Ergebnisse einer randomisierten, offenen Teilstudie mit Opioid-abhängigen Teilnehmern, die sich in Behandlung befinden	CI
15.11.	Jerome Lande scheidet aus dem Verwaltungsrat von Indivior plc aus	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

INDIVIOR : SHARE REPURCHASE PROGRAM WEEKLY REPORT Form 6 K	26.11.
Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024	20.11.
Indivior PLC Shares Results from a Randomized, Open-Label Sub-Study in Opioid-Dependent Participants Seeking Treatment	19.11.
Indivior : DIRECTOR DECLARATION Form 6 K	15.11.
Jerome Lande to Step Down from the Board of Indivior plc	15.11.
Indivior : Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above Form 6 K	12.11.
INDIVIOR : SHARE REPURCHASE PROGRAM WEEKLY REPORT Form 6 K	12.11.
Indivior : Note Purchase Agreement Form 6 K	08.11.
Indivior : Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior Form 6 K	08.11.
Indivior to talk with Oaktree after accusations of "value destruction"	08.11.
Indivior Shareholder Oaktree Capital Calls for Board Refresh	08.11.
Oaktree Capital urges UK's Indivior to refresh board	07.11.
Oaktree Capital Sends a Letter to Indivior PLC	07.11.
Indivior : Completes Refinance of Secured Term Loan; Enhances Liquidity and Financial Flexibility Form 6 K	05.11.
INDIVIOR : SHARE REPURCHASE PROGRAM WEEKLY REPORT Form 6 K	05.11.
Indivior completes refinancing of secured term loan	05.11.
Indivior Secures $400 Million Debt Financing	05.11.
Indivior PLC Completes Refinance of Secured Term Loan	05.11.
Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month	31.10.
INDIVIOR : SHARE REPURCHASE PROGRAM WEEKLY REPORT Form 6 K	29.10.
Indivior shares jump as backs guidance despite stiff competition	24.10.
Indivior : Q3 and YTD 2024 Financial Results Form 6 K	24.10.
Tranche Update on Indivior PLC's Equity Buyback Plan announced on July 25, 2024.	24.10.
Indivior PLC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	24.10.
INDIVIOR : SHARE REPURCHASE PROGRAM WEEKLY REPORT Form 6 K	22.10.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Indivior PLC

Aktien

A3DWFC

GB00BN4HT335

INDV

Pharmazeutika

Andere Sprachen

Filter